jueves, 12 de septiembre de 2019

Acadia Pharma's positive trial results call the bearish view into question

Acadia Pharma's positive trial results call the bearish view into question

Go West

STAT Plus: The bearish view of Acadia Pharma’s antipsychotic drug takes a hit with positive trial results

By ADAM FEUERSTEIN


Did Acadia's critics fail to appreciate the cleverness of designing a clinical trial for a mediocre medicine that could still deliver positive results?

No hay comentarios: